Changes of Serum VEGF, bFGF and HIF-1α Levels in Patients with Liver Cancer Before and After TACE and Their Clinical Significances

doi:10.11748/bjmy.issn.1006-1703.2019.04.002

PDF(3637 KB)

Labeled Immunoassays and Clinical Medicine ›› 2019, Vol. 26 ›› Issue (4) : 546-549. DOI: 10.11748/bjmy.issn.1006-1703.2019.04.002

Changes of Serum VEGF, bFGF and HIF-1α Levels in Patients with Liver Cancer Before and After TACE and Their Clinical Significances

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 26(4): 546-549 https://doi.org/10.11748/bjmy.issn.1006-1703.2019.04.002

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3637 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2018-10-25	2018-11-20	2019-04-20
Issue Date
2019-05-03

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS